$2.31 0.02 (+0.87%)
11/24/2009 4:00 PM

Keryx Biopharmaceuticals (KERX)

CAPS Rating: 3 out of 5

A biopharmaceutical company focused on the acquisition, development and commercialization of medically important, novel pharmaceutical products for the treatment of life-threatening diseases, including diabetes and cancer.

Featured Broker Partners